Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Operating Activities
Net income (loss)	$ (56,526)	$ 13,967
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation of property and equipment	6,634	6,235
Amortization of other intangible assets	6,079	6,510
Amortization of debt issuance costs	0	523
Stock-based compensation expense	13,612	16,638
Equity-method loss	0	1,033
Deferred income taxes	(5,270)	(2,670)
Changes in operating assets and liabilities:
Accounts receivable	(3,321)	(16,257)
Inventories	(3,958)	(32,794)
Prepaid expenses and other assets	(15,466)	11,530
Accounts payable	(13,829)	(12,966)
Other current liabilities and income taxes	1,554	(8,529)
Deferred revenue and returns liability	1,804	4,478
Other non-current liabilities	(3,113)	(978)
Net cash used in operating activities	(71,800)	(13,280)
Investing Activities
Purchases of marketable securities	(9,794)	(66,113)
Sales of marketable securities	25,763	170,317
Maturities of marketable securities	55,188	157,734
Purchases of property and equipment	(2,047)	(7,657)
Proceeds from sale of equity investment	12,382	0
Net cash provided by investing activities	81,492	254,281
Financing Activities
Payments on debt	(45,000)	0
Repurchases of common stock	0	(17,608)
Payment of taxes withheld for vested stock awards	(1,048)	(6,931)
Proceeds from the issuance of common stock	341	0
Net cash used in financing activities	(45,707)	(24,539)
Increase (decrease) in cash and cash equivalents	(36,015)	216,462
Cash and cash equivalents at beginning of period	227,504	499,915
Cash and cash equivalents at end of period	$ 191,489	$ 716,377